2016 ASAP BioPharma Conference to Explore New Dimensions of Partnering With a Focus on Expanding Technology and Healthcare Alliances

Share Article

World’s leading event for biopharma and healthcare partnering professionals returns Sept. 7-9 to the Revere Hotel Boston Common with a program focused on the evolution of collaboration, including talks on post-election healthcare reform and enhancing productivity with the executive suite

The Association of Strategic Alliance Professionals (ASAP), the world’s leading professional association dedicated to the practice of alliance management, partnering, and collaboration, announced the theme and programming for the 2016 ASAP BioPharma Conference, Sept. 7-9, “New Faces, Unexpected Places in Partnering: The Foresight to Lead, the Foundation to Succeed,” to be held once again at the Revere Hotel Boston Common, Boston. This year’s conference theme revolves around key changes taking place in the evolving healthcare and life sciences ecosystem.

“A company can no longer be comfortable defining its space as just an asset partnership and reside within those confines,” commented ASAP CEO Michael Leonetti, CSAP. “The ecosystem is getting larger; the alliance manager’s enterprise now represents the company, its partners, and the entire healthcare system. Too many organizations are happy to keep you in your silo, but it won’t happen there. We limit our creation of value in our companies unless we harvest the enterprise.”

Registration opens at 7 a.m. on Wednesday, Sept. 7, followed by a series of developmental workshops and a timely keynote address, “Healing the U.S. Health Care System: Collaboration is Essential,” by Dr. Sam Nussbaum, strategic consultant, EGB Advisors, Inc. Nussbaum has been central to designing collaborative solutions among Anthem, HealthCore, hospital systems, the FDA, and public agencies to provide cost-effective, high-quality care. Nussbaum was responsible for HealthCore, Anthem’s clinical outcomes research subsidiary, as a former executive vice president of clinical health policy and chief medical officer at WellPoint, Inc. He has designed partnerships and addressed systemic problems at the highest levels within the private and public sector.

“As a healthcare policy guru, Dr. Nussbaum is well-positioned to discuss collaborative approaches he has forged with key stakeholders. He can help attendees envision and define ecosystem challenges and changes that may impact their strategic alliances,” remarked Leonetti about the choice. “As we explore how healthcare will be impacted by the presidential election, Dr. Nussbaum has the background to diagnose what the outcome could mean for each segment of the industry and prescribe solutions.”

Thursday morning opens with an insightful plenary session, “The View from the C-Suite: Partnering and Alliances Today and Tomorrow,” by Stéphane Thiroloix, CEO at Mayoly Spindler, a mid-level French pharmaceutical company with a focus on gastroenterology and dermocosmetics. Thiroloix will discuss how alliance management functions can be best viewed and leveraged by company senior leadership. He will provide perspective on new models of partnering and enhancing productivity in the boardroom between alliance management teams and the C-suite.

The remainder of the conference will be comprised of practical, cutting edge sessions focused on:

  • Sharing experiences and new viewpoints on front-line partnering innovation through structured breakout sessions and informal networking
  • Discovering proven frameworks, practices, and tools to drive partnering success
  • Exploring opportunities and managing partnering risks outside comfort zones, with an emphasis on high tech

“As biopharma expands, so has the conference, which will offer multiple opportunities for learning how to partner in new environments, such as tech, academic, and healthcare system partnerships,” emphasized Leonetti. “Several sessions will emphasize the value of partnering with the tech side of ASAP. They will provide key opportunities to learn about tech company expectations and how they partner.”

Working to bridge that gap, for example, are two progressive sessions: “New Partnerships Between High Tech and BioPharma and the Alliance Management Practices to Support Them,” facilitated by Donna Peek, CSAP, director, partner enablement & operations at SAS Institute, and “New Partnerships between High Tech and BioPharma and the Alliance Management Practices to Support Them,” led by Russ Buchanan, CSAP, head of corporate alliances, Xerox Corporation.

ASAP also will be unveiling, along with its author, a groundbreaking new study The Economics of Alliances, Social Capital, and Alliance Performance, which is scheduled for release after the conference as ASAP’s 6th State of Alliances study. Dr. Shawn Wilson, the author, has analyzed reams of data, extensively surveyed ASAP members, and worked with ASAP to provide new financial and economic ROI analytics that reflect partnering best practices. In addition to Wilson’s data, Stuart Kliman, CA-AM, will presenting Vantage Partners’ own research findings Cross-Industry Review of Alliance Management Trends and Challenges.

Several session leaders will be sharing their views on “Strategic Perspectives on a Partnership's First 100 Days,” which will offer a range of experiences on partnering with new players. As the borders continue to “dissolve,” alliance managers, CEOs, and others are brushing up on their cultural understanding. One dynamic session that will broach this topic is “A New Model for Western and Chinese Pharmaceutical Partnering,” by Brent Harvey, CA-AM, director, alliance management at Eli Lilly and Company.

Attendees also will be given the chance to become participants in a new, interactive ASAP Aquarium session “Strengthening our Partnership Capabilities,” facilitated by Jan Twombly, CSAP, and president of The Rhythm of Business, Inc. Industry thought leaders and senior-level partnering executives will engage in deep discussions that audience members can “tap into” and replace a participant onstage. As the new member joins the group, the conversation shifts with new perspectives. Twombly and her partner at The Rhythm of Business, Jeff Shuman, CSAP, also will be facilitating a 90-minute workshop that introduces participants to design thinking centered on innovation and complex problem solving methodologies, “Using Design Thinking to Drive Speed, Innovation, and Alignment in Partnering.”

Back by popular demand is Ben Gomes-Cassares, CSAP, with a primer on how to avoid the pitfalls that he says lead to half of all alliance failures in “Making Better Alliances: How Alliance Management, Business Development, and Legal Can Collaborate More Effectively.”

For more information about the conference speakers and sessions, go to http://www.asapweb.org/biopharma/bio16sessions.html.

About ASAP
The Association of Strategic Alliance Professionals (ASAP) is the only professional association dedicated to elevating and promoting the profession of alliance management and partnerships. Founded in 1998, the organization provides professional development, networking and resources for cultivating the skills and toolsets needed to manage successful business partnerships. ASAP’s professional certifications include the Certificate of Achievement-Alliance Management (CA-AM) and Certified Strategic Alliance Professional (CSAP). Active global members include AbbVie, Astellas, AstraZeneca, Bayer, Capgemini, Cisco, Citrix, Covance, Dell, Eli Lilly and Company, HealthCore, Huawei, IBM, INC Research, Janssen—Pharmaceutical Companies of Johnson & Johnson, Merck, Mission Pharmacal, NetApp, Novartis, Plantronics, Sanofi, SAS, Schneider Electric, Takeda, The Warren Company, and Xerox. A complete list of global members is available at http://www.strategic-alliances.org.

Register now to take advantage of Early Bird savings. For more information please visit http://www.asapweb.org/biopharma/ or contact Michele Shannon at +1-774- 256-1401.

Share article on social media or email:

View article via:

Pdf Print